Quale sarebbe il prezzo per Entia Biosciences, Inc. (ERGO)

Il prezzo per Entia Biosciences, Inc. (ERGO) è $0.0002

Qual è la capitalizzazione di mercato per Entia Biosciences, Inc. (ERGO)

La capitalizzazione di mercato per Entia Biosciences, Inc. (ERGO) è $6.73K

Entia Biosciences, Inc. (ERGO) Azioni in Circolazione

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.

Anno	Azioni in circolazione	Cambia
Non abbastanza dati per le date fornite.

Anno

Azioni in circolazione

Cambia

Non abbastanza dati per le date fornite.

Azienda	Azioni in circolazione	Differenza	Il paese
Royalty Pharma plc RPRX.US	445.06M	-	US
Swedish Orphan Biovitrum AB SOBI.ST	-	-	SE
Ipsen S.A. IPN.PA	-	-	FR
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	-	-	IT
Corcept Therapeutics Incorporated CORT.US	105.38M	-	US

Azienda

Azioni in circolazione

Differenza

Il paese